4//SEC Filing
Gardiner Nathaniel S. 4
Accession 0001062993-23-022053
CIK 0001177648other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 8:26 PM ET
Size
6.4 KB
Accession
0001062993-23-022053
Insider Transaction Report
Form 4
Gardiner Nathaniel S.
Sr. VP & General Counsel
Transactions
- Sale
Common Stock
2023-12-05$9.63/sh−2,412$23,228→ 68,154 total
Holdings
- 35,926(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents shares sold by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 23, 2022, as required pursuant to the terms of the award. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.47 to $9.63, inclusive. The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth set forth in this footnote of this Form 4.
- [F3]These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001607643
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 8:26 PM ET
- Size
- 6.4 KB